Funding Rounds

A domestic manufacturer of high-end ophthalmologic medical devices that develops and provides surgical equipment, consumables, and training services for ophthalmic solutions, including phacoemulsification-vitrectomy combination machines and other advanced eye surgery devices.

A medical device company specializing in high-end ophthalmic equipment including OCT systems, surgical microscopes, and laser-assisted cataract surgery systems, with technology originating from Tsinghua University.

Qiangsi Digital Technology develops spatial AI and industrial software solutions for 3D reconstruction and digital modeling of industrial facilities, enabling high-precision industrial world models and autonomous operations in complex manufacturing environments.

Jingxiang Technology develops M1, a vertical emotional psychology large language model focused on AI emotional companionship with emphasis on professional expertise, empathy, and safety. The technology is designed for both medical-grade scenarios and consumer-level applications.

A synthetic biology new materials company focused on mycelium fiber material research and production, utilizing fermentation technology to create bio-based materials for packaging, construction, and fashion applications.

A biotech company focused on innovative antibody drug development for treating inflammatory and autoimmune diseases, with operations in Beijing, China and Cambridge, UK.

Airies is a contact lens manufacturer specializing in intelligent manufacturing of silicone hydrogel lenses with proprietary production processes and equipment design, offering advanced optical properties and eye health innovations.

A clinical-stage small nucleic acid drug company focused on developing innovative therapies for kidney disease and metabolic disorders, with lead pipeline in IgA nephropathy treatment.

A global robot rental platform that serves as rental infrastructure for the robotics industry, connecting asset suppliers with users across manufacturing, retail, and entertainment sectors.

AeroBand develops intelligent musical instruments including digital guitars and smart electronic drums that use sensor technology and audio synthesis to lower the barrier to entry for music learning and allow zero-basis users to quickly experience music enjoyment.

A biotech company specializing in nanopore gene sequencing technology with full-stack self-developed capabilities including nanopore protein modification, single-molecule base recognition, high-integration silicon-based chips, and high-fidelity signal acquisition systems.

A company focused on developing high-capacitance silicon capacitor products and advanced packaging technologies for semiconductor applications.

Newbonbio is a dietary supplement ingredient company focused on research and development of innovative functional raw materials using pharmaceutical-grade R&D approaches. The company operates across synthetic biology, chemical synthesis, plant extraction, and technical formulation to develop high-purity, high-stability products for weight management, muscle building, blood sugar control, anti-aging, brain health, and immune support.

An AI-driven full-stack protein research and development platform company that uses large language models and automated experimental systems to design functional proteins for drug discovery, healthcare, agriculture, and biotech applications.

An embodied AI company that develops general-purpose robotic operation solutions with human-machine collaborative intelligence, enabling robots with reliable and flexible manipulation capabilities for household applications.

A global embodied perception-driven general intelligence company that develops high-precision tactile hardware and builds a human-centric high-precision data collection system, operating massive data acquisition factories to produce multimodal perception data.

An exoskeleton robotics company developing wearable exoskeleton products designed to enhance human mobility and address physical limitations, with applications across medical, athletic, entertainment, and consumer sectors.

A global innovative cell therapy company focused on developing CAR-T cell therapies for solid tumors, with proprietary platforms including next-generation CAR-T technology and in vivo CAR-T generation technology.

Weimmai Medical is a research and development company specializing in energy medicine technology, particularly high-energy monopolar radiofrequency devices for aesthetic medicine. The company has developed an integrated platform for research, development, production, and sales of energy medicine solutions with proprietary technologies including pulse flash technology, dynamic intelligent temperature control, and AI energy impedance matching.

A hard-tech company focused on developing heavy-load all-terrain modular deformable robots for agriculture and other outdoor work scenarios. The company designs unified robot chassis that can be adapted with different functional modules to handle complex field environments and diverse task requirements.

A near-commercialization biotech company focused on developing innovative drugs for chronic metabolic diseases, leveraging proprietary E. coli production platforms and long-acting peptide technologies.

Chromai is a leading domestic high-end liquid chromatography company that develops and produces ultra-high-performance liquid chromatography (UHPLC) systems and related analytical instruments for applications in pharmaceutical, food testing, environmental monitoring, and chemical analysis.